RecruitingNCT04274283
Tessa Jowell BRAIN MATRIX - Platform Study
Studying Embryonal tumor of neuroepithelial tissue
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Birmingham
- Principal Investigator
- Colin WattsUnviersity of Birmingham
- Intervention
- Matched Tumour and Blood Sample - Research Pathway(other)
- Enrollment
- 1000 target
- Eligibility
- 16 years · All sexes
- Timeline
- 2020 – 2028
Study locations (14)
- Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
- Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
- Velindre Cancer Centre, Velindre University NHS Trust, Cardiff, United Kingdom
- NHS Lothian, Edinburgh, United Kingdom
- Queen Elizabeth Unviersity Hospital, NHS Greater Glasgow and Clyde Health Board, Glasgow, United Kingdom
- St James's University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
- The Walton Centre, The Walton Centre NHS Foundation Trust, Liverpool, United Kingdom
- King's College Hospital, King's College Hospital NHS Foundation Trust, London, United Kingdom
- Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
- The Christie Hospital, The Christie NHS Foundation Trust, Manchester, United Kingdom
- Salford Royal Hospital, Northern Care Alliance NHS Foundation Trust, Manchester, United Kingdom
- Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
- Queen's Medical Centre, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
- Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
Collaborators
The Brain Tumour Charity · University of Oxford · University of Edinburgh · Genomics England
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04274283 on ClinicalTrials.govOther trials for Embryonal tumor of neuroepithelial tissue
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07488754Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) In Newly Diagnosed Glioma (WHO G3-G4)Medical University of Warsaw
- RECRUITINGPHASE1NCT07025018Phase I Study of HMPL-306 for the Treatment of Gliomas With IDH1 and/or IDH2 MutationsHutchmed
- RECRUITINGNANCT06719440Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target VolumeCliniques universitaires Saint-Luc- Université Catholique de Louvain
- RECRUITINGPHASE2NCT06558214OPTIMUS PRIME: Safety and Feasibility of OPTune GIO® Integrated With MRI-gUided Laser Ablation Surgery and Pembrolizumab for Recurrent GlIoblastoMa, A randomizEd TrialUniversity of Florida
- RECRUITINGPHASE3NCT06496971A Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme PatientsNaviFUS Corporation
- RECRUITINGPHASE2NCT07364786Effect of Salovum® on Pressure, Oxygen and Inflammation in GlioblastomaPeter Siesjö
- RECRUITINGEARLY PHASE1NCT06828341A Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refractory Brain Gliomas With Positive CD70 ExpressionJIANG LONGWEI
- RECRUITINGPHASE2NCT05708352A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care TreatmentCedars-Sinai Medical Center
See all trials for Embryonal tumor of neuroepithelial tissue →